@MrMichaelNye@XeophinBio we’re tokenising half of the royalty stream for a class leading drug to treat TNF mediated conditions, which include Rheumatoid Arthritis. We believe we’ll be the first drug dev co to go down this path...
We’re looking forward to building a suite of Gene Therapies based on rapid screening using our PROScreen Gene Discovery Platform. Exciting times ahead! #genetherapy#biotech#Pharmaceutical
Value begins with great tech and a solid business underpinning the value, and this can only be achieved with a great team. Avoid the “Look at our Advisors” offerings. Paid faces don’t equal value. #ico#blockchain#CryptoNews#biotech#arthritis#TokenSale#token
@jdavidsonlawyer @stephendpalley No John you weren’t, but as a lawyer, I’m sure you appreciate the value of meaningful dialogue. What we do will have an impact on people’s lives, and we just want to ensure our message is out there. Feel free to email [email protected] to continue the conversation. Take care.
@stephendpalley We’re very proud of our project. We have a patented product to treat Rheumatoid Arthritis, a debilitating condition backed by a great team. If you have any other issues, feel free to contact us directly [email protected]
@stephendpalley Hello Palley, firstly apologies, one of our marketing connections has been less than forthright with where their networks are sourced. So obviously the first thing you should do is unsubscribe if it’s not something you’re interested in.
@jdavidsonlawyer @stephendpalley Hi John. We’re very proud of the work we’re doing in the Biotech space. Drug development is a tough undertaking at the best of times. Knowledge, fortitude and resilience are the requirements we draw on. Weakness isn’t in our vocabulary.
@KyleSGibson@stephendpalley Hello Kyle. We’re very proud of our project. We have a patented product to treat Rheumatoid Arthritis, a debilitating condition, with clinical trials on the horizon, backed by a great team. A 3-5 year timeline doesn’t make for a good exit scam...!